Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces.

ABSTRACT:

Background

Confidential product listing agreements (PLAs) negotiated between pharmaceutical manufacturers and individual health care payers may contribute to unwanted price disparities, high administrative costs, and unequal bargaining power within and across jurisdictions. In the context of Canada's decentralized health system, we aimed to document provincial policy makers' perceptions about collaborative PLA negotiations.

Methods

We conducted semi-structured telephone interviews with a senior policy maker from nine of the ten Canadian provinces. We conducted a thematic analysis of interview transcripts to identify benefits, drawbacks, and barriers to routine collaboration on PLA negotiations.

Results

Canadian policy makers expressed support for joint negotiations of

SUBMITTER: Morgan SG 

PROVIDER: S-EPMC3563436 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature